🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This surveillance was designed as a prospective, open-label, multicenter, s...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2022-05-09
Trial ID
NCT05217810
The purpose of this study is to compare the effectiveness and safety of ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01555138
Treatments Being Tested
This study compared the efficacy of indacaterol versus placebo in COPD pati...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-04-28
Trial ID
NCT02418468
Treatments Being Tested
The purpose of this study is to compare in COPD patients naïve to DPIs, the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02551224
Treatments Being Tested
Preference study: Genuair® (Pressair™) vs Breezhaler® (Neohaler™) inhalers ...
Status
Completed
Location
Almirall investigative site 2
Start Date
2013-07
Trial ID
NCT01915784
Treatments Being Tested
This study evaluates hospitalizations and mortality in patients with Chroni...
Status
Completed
Location
Boehringer Ingelheim Brasil
Start Date
2021-04-01
Trial ID
NCT06053541
Exercise intolerance is a major complain of patients with chronic obstructi...
Status
Completed
Location
Pavilhão Pereira Filho
Start Date
2013-03
Trial ID
NCT01693003
Treatments Being Tested
This study will assess the Efficacy of NVA237 (50 μg o.d) using tiotropium ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT01837927
Treatments Being Tested
This clinical study was designed to assess the pharmacokinetics, safety and...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-06-07
Trial ID
NCT04589663
Treatments Being Tested
This is a formulation feasibility study to to compare relative bioavailabil...
Status
Completed
Location
CRST Helsinki Oy
Start Date
2022-02-28
Trial ID
NCT05288075
Treatments Being Tested